SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001558370-24-005679
Filing Date
2024-04-25
Accepted
2024-04-25 07:01:37
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A tmb-20240425xdefa14a.htm DEFA14A 16205
2 GRAPHIC tmb-20240425xdefa14a_bg001.jpg GRAPHIC 159969
3 GRAPHIC tmb-20240425xdefa14a_bg002.jpg GRAPHIC 104431
  Complete submission text file 0001558370-24-005679.txt   381622
Mailing Address 701 LEE ROAD SUITE 103 WAYNE PA 19087
Business Address 701 LEE ROAD SUITE 103 WAYNE PA 19087 484-324-7933
Aclaris Therapeutics, Inc. (Filer) CIK: 0001557746 (see all company filings)

IRS No.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37581 | Film No.: 24872836
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)